Emergence of Aspergillus calidoustus Infection in the Era of Posttransplantation Azole Prophylaxis

被引:39
作者
Egli, Adrian
Fuller, Jeff [2 ]
Humar, Atul
Lien, Dale [3 ]
Weinkauf, Justin [3 ]
Nador, Roland [3 ]
Kapasi, Ali [3 ]
Kumar, Deepali [1 ]
机构
[1] Univ Alberta, Rexall Ctr Hlth Res, Katz Grp 6 030, Edmonton, AB T6G 2E1, Canada
[2] Univ Alberta, Prov Lab Publ Hlth, Edmonton, AB T6G 2E1, Canada
[3] Univ Alberta, Lung Transplant Program, Edmonton, AB T6G 2E1, Canada
基金
瑞士国家科学基金会;
关键词
Immunosuppression; Solid organ transplantation; Hematopoietic stem-cell transplant; Antifungal therapy; ORGAN TRANSPLANT RECIPIENTS; STEM-CELL TRANSPLANTATION; INVASIVE ASPERGILLOSIS; ANTIFUNGAL PROPHYLAXIS; LUNG TRANSPLANTATION; USTUS INFECTION; CUTANEOUS INFECTION; FUNGAL-INFECTIONS; VORICONAZOLE; DEFINITIONS;
D O I
10.1097/TP.0b013e31825992f0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Universal antifungal prophylaxis with azoles is commonly used after lung transplantation. We noted an increase in isolates of Aspergillus calidoustus in our transplant population and hypothesized that increasing azole use (universal prophylaxis since 2008) may be promoting this infection. Methods. Clinical and microbiologic data for A. calidoustus cases from 2008 to 2011 were extracted from chart review. For lung transplant patients, a case-control study was performed to determine risk factors, and incidence rates were calculated. Results. From 2008 to 2011, we identified seven organ transplant recipients and one hematopoietic stem-cell transplant patient with positive A. calidoustus culture results in bronchoalveolar lavage at a median of 13 months after transplantation (interquartile range, 4-39 months). Chest computed tomographic scan was consistent with fungal infection in six of eight patients, and the European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria classified these as "probable" invasive aspergillosis. In the case-control study, there were no differences in immunosuppression, number of respiratory samples taken, length of intensive care unit stay, or rejection rates. Of controls, 33.3% received third-generation azole prophylaxis compared with 83.3% of cases (P=0.13). However, median duration of exposure was greater in cases than in controls (3 vs. 0 months, P=0.045). Fungal minimum inhibitory concentration for voriconazole was 4 Hg/mL or greater for six of eight cases. Incidence rates in lung transplants showed an increase of A. calidoustus (0/1000 vs. 11.3/1000 patient-years in 2006-2007 and 2008-2011, respectively; P=0.018), whereas Aspergillus fumigatus cases decreased (73.9/1000 vs. 49.0/1000 patient-years, P=0.0066). Conclusions. Pulmonary A. calidoustus seems to be an emerging pathogen mainly in lung transplants. We suggest that third-generation azole use reduced the incidence of A. fumigatus, but the incidence of A. calidoustus, an azole-resistant fungus, was increased.
引用
收藏
页码:403 / 410
页数:8
相关论文
共 30 条
[1]   In vitro activity of nine antifungal agents against clinical isolates of Aspergillus calidoustus [J].
Alastruey-Izquierdo, Ana ;
Cuesta, Isabel ;
Houbrakent, Jos ;
Cuenca-Estrella, Manuel ;
Monzon, Araceli ;
Rodriguez-Tudela, Juan L. .
MEDICAL MYCOLOGY, 2010, 48 (01) :97-102
[2]   Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection [J].
Azzola, A ;
Passweg, JR ;
Habicht, JM ;
Bubendorf, L ;
Tamm, M ;
Gratwohl, A ;
Eich, G .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (10) :4805-4808
[3]   Patterns of Susceptibility of Aspergillus Isolates Recovered from Patients Enrolled in the Transplant-Associated Infection Surveillance Network [J].
Baddley, John W. ;
Marr, Kieren A. ;
Andes, David R. ;
Walsh, Thomas J. ;
Kauffman, Carol A. ;
Kontoyiannis, Dimitrios P. ;
Ito, James I. ;
Balajee, S. Arunmozhi ;
Pappas, Peter G. ;
Moser, Stephen A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (10) :3271-3275
[4]   Invasive mold infections in allogeneic bone marrow transplant recipients [J].
Baddley, JW ;
Stroud, TP ;
Salzman, D ;
Pappas, PG .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (09) :1319-1324
[5]   Serum Aspergillus galactomannan antigen testing by sandwich ELISA: Practical use in neutropenic patients [J].
Bretagne, S ;
MarmoratKhuong, A ;
Kuentz, M ;
Latge, JP ;
BartDelabesse, E ;
Cordonnier, C .
JOURNAL OF INFECTION, 1997, 35 (01) :7-15
[6]   Concomitant pulmonary infection with Nocardia transvalensis and Aspergillus ustus in lung transplantation [J].
Cabada, Miguel M. ;
Nishi, Shawn P. ;
Lea, Alfred S. ;
Schnadig, Vicki ;
Lombard, Gisele A. ;
Lick, Scott D. ;
Valentine, Vincent G. .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (08) :900-903
[7]   Antifungal Prophylaxis with Voriconazole or Itraconazole in Lung Transplant Recipients: Hepatotoxicity and Effectiveness [J].
Cadena, J. ;
Levine, D. J. ;
Angel, L. F. ;
Maxwell, P. R. ;
Brady, R. ;
Sanchez, J. F. ;
Michalek, J. E. ;
Levine, S. M. ;
Restrepo, M. I. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 (09) :2085-2091
[8]   Trends in antifungal susceptibility testing using CLSI reference and commercial methods [J].
Canton, Emilia ;
Espinel-Ingroff, Ana ;
Peman, Javier .
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2009, 7 (01) :107-119
[9]   Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [J].
De Pauw, Ben ;
Walsh, Thomas J. ;
Donnelly, J. Peter ;
Stevens, David A. ;
Edwards, John E. ;
Calandra, Thierry ;
Pappas, Peter G. ;
Maertens, Johan ;
Lortholary, Olivier ;
Kauffman, Carol A. ;
Denning, David W. ;
Patterson, Thomas F. ;
Maschmeyer, Georg ;
Bille, Jacques ;
Dismukes, William E. ;
Herbrecht, Raoul ;
Hope, William W. ;
Kibbler, Christopher C. ;
Kullberg, Bart Jan ;
Marr, Kieren A. ;
Munoz, Patricia ;
Odds, Frank C. ;
Perfect, John R. ;
Restrepo, Angela ;
Ruhnke, Markus ;
Segal, Brahm H. ;
Sobel, Jack D. ;
Sorrell, Tania C. ;
Viscoli, Claudio ;
Wingard, John R. ;
Zaoutis, Theoklis ;
Bennett, John E. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (12) :1813-1821
[10]   Cerebral aspergillosis caused by Aspergillus ustus following orthotopic heart transplantation: case report and review of the literature [J].
Florescu, Diana F. ;
Iwen, Peter C. ;
Hill, Lisa A. ;
Dumitru, Ioana ;
Quader, Mohammed A. ;
Kalil, Andre C. ;
Freifeld, Alison G. .
CLINICAL TRANSPLANTATION, 2009, 23 (01) :116-120